HIGHLAND CAPITAL MANAGEMENT, LLC - PERNIX THERAPEUTICS HLDGS IN ownership

Quarter-by-quarter ownership
HIGHLAND CAPITAL MANAGEMENT, LLC ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q3 2016$26,000
+44.4%
41,0000.0%0.00%0.0%
Q2 2016$18,000
+5.9%
41,000
+156.2%
0.00%
+100.0%
Q1 2016$17,000
-79.3%
16,000
-38.5%
0.00%
-85.7%
Q3 2015$82,000
-33.9%
26,000
+23.8%
0.01%
-30.0%
Q2 2015$124,000
+5.1%
21,000
+90.9%
0.01%
-56.5%
Q1 2015$118,00011,0000.02%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 1,134,578$10,654,0007.22%
Consonance Capital Management LP 3,427,789$32,187,0004.15%
ACUTA CAPITAL PARTNERS, LLC 604,075$5,672,0003.83%
KOPP INVESTMENT ADVISORS LLC 758,233$7,119,0003.42%
Aisling Capital LLC 2,010,000$18,874,0002.86%
Broadfin Capital, LLC 6,100,000$57,280,0002.49%
THOMPSON DAVIS & CO., INC. 154,760$1,453,0001.68%
RUDMAN ERROL M 300,000$2,817,0001.14%
WALL STREET ASSOCIATES 1,259,500$11,827,0001.13%
Timpani Capital Management LLC 291,377$2,736,0001.08%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders